ILUVIEN(R) is now widely available to diabetic macular edema patients throughout the U.S.
Alimera announced retina specialists in the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina. April 21, 2015